We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PAR market cap is 99.88M. The company's latest EPS is AUD -0.1481 and P/E is -1.89.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 2.98M | 3.7M | 8.42M | 7.84M | 7.18M |
| Operating Income | -8.96M | -13.26M | -34.78M | -40.17M | -52.91M |
| Net Income | -15.63M | -12.3M | -34.3M | -39.25M | -51.91M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 85.51M | 112.36M | 84.79M | 50.69M | 67.07M |
| Total Liabilities | 2.71M | 4.18M | 6.52M | 8.38M | 13.39M |
| Total Equity | 82.81M | 108.18M | 78.27M | 42.31M | 53.68M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -6.37M | -10.09M | -34.93M | -32.21M | -45.19M |
| Investing | -6.52M | 5.62M | 668k | N/A | N/A |
| Financing | 82.78M | 36.05M | 1M | 70k | 62.54M |
| Market Cap | 99.88M |
| Price to Earnings Ratio | -1.89 |
| Price to Sales Ratio | 13.66 |
| Price to Cash Ratio | 1.74 |
| Price to Book Ratio | 1.83 |
| Dividend Yield | - |
| Shares Outstanding | 350.46M |
| Average Volume (1 week) | 392.03k |
| Average Volume (1 Month) | 474.11k |
| 52 Week Change | -72.60% |
| 52 Week High | 1.115 |
| 52 Week Low | 0.265 |
| Spread (Intraday) | 0.01 (3.45%) |
| Company Name | Paradigm Biopharmaceuticals Ltd |
| Address |
level 15 melbourne, victoria 3000 |
| Website | https://www.paradigmbiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
